As part of an ongoing study of the response of the Streptococcus pneumoniae population to conjugate vaccination, we applied multi-locus sequence typing (MLST) to 291 isolates sampled from nasopharyngeal carriage in Massachusetts children. We found 94 distinct sequence types (STs), including 19 that had not been previously recorded, and a xpt allele containing a large insertion. Comparison with a similar sample collected in 2007 revealed no significant overall difference in the ST composition (p=0.51) suggesting that the population has reached a new equilibrium following the introduction of 7 valent vaccination in 2000. Within serotypes, a large and statistically significant increase (p=0.014 Fisher's Exact test) was noted in the prevalence of the major multiresistant clone ST 320, which is apparently outcompeting ST 199 among serotype 19A strains. This sample will be used as a baseline to study the future evolution of the pneumococcal population in Massachusetts following introduction of vaccines with higher valency.
Introduction
The implementation of a conjugate vaccine against seven pneumococcal serotypes (PCV-7) has been followed by the near disappearance of vaccine types (VTs) as causes of invasive disease and asymptomatic carriage [1] [2] [3] . However, non-vaccine types (NVTs) have become more common in carriage, such that the overall carriage prevalence of pneumococcus has remained constant, a phenomenon known as serotype replacement. The increased exposure to NVTs in carriage has been followed by a small but significant increase in invasive pneumococcal disease (IPD) due to these serotypes [4] , in particular 19A [2] . A new 13 valent vaccine (PCV-13) extends coverage to some of the NVTs which have been documented in IPD both in the US and elsewhere, including 19A. PCV-13 has been introduced into the routine immunisation schedule in the US. It is anticipated that this will address some of the continued morbidity due to pneumococcal serotypes not covered by PCV-7, as well as leading to another round of serotype replacement in carriage and IPD the consequences of which are unknown.
Pneumococcal serotypes are typically made up of several lineages or clones, which are readily distinguished using multi-locus sequence typing (MLST) [5] . MLST characterises strains based on the combinations of alleles at seven different housekeeping loci scattered around the genome, which together determine the sequence type (ST). MLST is a useful molecular tool for the characterization of pneumococcal clones because, in most cases, features such as antibiotic resistance or serotype, as well as the presence of accessory loci such as pilus [6] , are clonal properties, meaning that two strains with the same ST are likely to share them as a result of common ancestry. ST can therefore be used to characterise clones and their properties (for a review of such clonal analyses, see [7] ). The pneumococcus is, however, naturally transformable; it is able to take up homologous DNA from other strains and incorporate it into its genome. As a result of such recombination events, genes including those encoding serotype or antimicrobial resistance may be transferred between clones, and over the longer term this diversification will reach the point at which isolates identical by MLST exhibit multiple serotypes or resistance profiles and the association between ST and phenotype breaks down. The diversification of one such lineage (ST 81, or PMEN 23F -1) was recently explored by whole genome sequencing, and showed substantial variation arising over the period of a few decades [8] . Serotype switching refers to the process by which the loci determining serotype are transferred between STs, leading to organisms with the same ST expressing more than one capsular type.
We have previously used MLST to study the effect of vaccination with PCV-7 on the carried pneumococcal population among Massachusetts children, through longitudinal samples collected in the community in 2001, 2004 and 2007 [9, 10] . By 2007, the clonal composition of the pneumococcal population had changed dramatically in response to immunization. Nevertheless, by this time, the relative prevalence of different serotypes appeared similar to that observed in pre-vaccine samples, interpreted as evidence that replacement in carriage has led to a new equilibrium in which 19A is the most common serotype in carriage and disease [11] . Between 2001 and 2007, we have been able to document the emergence in carriage, and expansion of important STs in the post vaccine era Some of these have been documented to be increasingly important in resistance and invasive disease [12, 13] , and have apparently been generated by serotype switching [14] . We now report the further evolution of the pneumococcal population as determined by sampling from the same communities in 2009. This allows us to document clonal changes within serotypes, and also provides a baseline for continued study following introduction of PCV-13.
Materials and methods

Data collection
Carried pneumococcal strains were collected by nasopharyngeal swab from children aged from 3 months to 7 years of age, between October 2008 and April 2009, from children attending pediatric and family medicine practices for well-child or acute illness visits in 8 Massachusetts communities. Parental consent was obtained by study staff and nasopharyngeal swabs were obtained by trained nurses [9] . All study procedures were approved by the Harvard Pilgrim Health Care institutional review board. Samples were processed for S. pneumoniae growth, antibiotic susceptibility, and serotype using the quellung reaction as previously described [15] . Strains were maintained as glycerol stocks at −80°C and DNA was purified using DNeasy tissue kits (Qiagen, Valencia, CA). We consider 15B and 15C to be a single, rapidly interconverting serotype, 15B/C. The results from the 2008-9 sample were compared with samples from the same communities in the 2006-7 season which have previously been described in detail [9] .
Multilocus Sequence Typing (MLST)
Sequence types (STs) of isolates were determined by MLST as previously described [5] . Sequences of each of the seven gene fragments used in the pneumococcal MLST scheme were obtained using an ABI 3730xl DNA analyzer. The sequences were aligned and trimmed to defined start and end positions using MEGA version 4 [16] . Allele and ST assignments were made using the MLST website (www.spneumoniae.mlst.net). All alleles not already present in the pneumococcal MLST database were verified by re-sequencing the gene fragment on both strands. In one isolate, a large insertion was found in the xpt locus. For this isolate the usual forward and reverse primers for xpt were used together with an additional pair of primers located within the insert to amplify and sequence the entire locus (xpt Insert Forward:CAGAGAACTGGCAGACACGA; xpt Insert Reverse:AAAAACAGGGCAATACTACCTCA). For STs found among isolates of more than one serotype the MLST loci were resequenced and serotypes were confirmed by Quellung reaction.
Analysis
Differences in the ST composition of the two populations were estimated using the classification index, with significance assessed using a permutation method as previously described [10, 17] . eBURSTv3 software was used to compare the population structures in 2007 and 2009 [18] . This program groups related STs into clonal complexes (CCs), identifies the probable ancestor of each clonal complex and outputs a graphical representation of these relationships. This enabled us to assess the frequency of CCs of related strains in the 2009 sample and compare them with the sample collected in 2007 [10] . Fisher's exact test was used to assess the significance of ST changes in each serotype. For individual STs and CCs Fisher's exact test was used to test for the significance of changes in frequency compared to all other STs and clonal complexes in the serotype. The R statistical package was used in the analysis [19] .
Results
Summary 94 distinct STs were found, 19 of which had not been previously recorded. Those present 5 or more times in the sample, and the serotypes associated with them, are shown in Table 1 and the complete results are presented in the supplementary results (SOM Table 1 ). Several alleles were recorded that were new to the MLST database; 2 gdh, 2 gki, 1 recP, 1 spi, 2 xpt and 2 ddl. One of the novel xpt alleles was found to contain a large ~1.7kb insertion starting at position 358 within the locus. The ancestral allele was xpt 31. Sequencing of a total of 1kb of the insert using normal MLST primers allowed us to design additional primers located within it, which were sufficient to obtain full sequence. Comparison with BLAST results suggested it was a Spn1 transposase (>99% sequence identity). This xpt allele is deposited at the MLST website (www.spneumoniae.mlst.net) in the non-standard length alleles database as allele 324.
We asked whether the 2007 and 2009 samples were significantly different in their ST composition with the classification index [17] . This test calculates a statistic for the similarity between two populations, and then randomly permutes the pooled populations into two samples of the same size to estimate how the test statistic is distributed under the null hypothesis of the two samples being from the same population. We found no 
Changes within individual serotypes
Changes in the 19A and 6C populations between 2007 and 2009 are shown in Figure 2 . The only significant difference in ST composition as assessed by Fisher's exact test is in the 19A sample (p=0.014). This is due to a decline in ST 199, which is paralleled by the increase in ST 320 and related strains. No significant differences were observed in the populations within serotypes 23A, 15B/C, or 6C, although the marked increase in ST 138 in the 6C population should be noted.
Discussion
We have previously used MLST to characterise samples of carried pneumococci from MA children collected in 2001, 2004 and 2007 . In this paper, we report the results of the MLST analysis of the most recent sample, collected in 2009. In marked contrast with all the previous samples, the 2009 sample was not found to be significantly different in terms of overall ST composition from the 2007 sample (CI; p=0.51). This is in contrast with all previous consecutive samples [9, 10] , which showed a continuous process of change in the STs composing the population, reflecting the process of serotype replacement that we have described previously. It has previously been shown that by 2007 the population structure of carried serotypes, in terms of diversity, was similar to that observed in the absence of vaccination [11] , an observation which was interpreted as a result of the serotype distribution reaching a new equilibrium in the presence of vaccination. We interpret the similarity between the ST composition of the 2009 and 2007 samples as reflecting this new equilibrium.
Our finding of a xpt allele harbouring a large insertion should be understood in the context of other alleles found at this locus. The MLST database contains, at the time of writing, 15 alleles at the xpt locus that contain insertions or deletions (including allele 324, which we report here. See www.spneumoniae.mlst.net). No alleles of the other MLST loci have been found containing insertions or deletions. This may indicate that the xpt locus can be lost or severely mutated with little or no selective consequence. In further support of this, 12 of the recorded xpt alleles at www.spneumoniae.mlst.net contain premature stop codons. In parallel, ST 695 has continued to be an increasingly important ST in 19A. Both these STs were previously associated with vaccine serotypes, and demonstrate the ability of successful pneumococcal clones to respond to selective pressures [8] . This capacity will continue to be important as we observe the implementation of new vaccines covering an expanded repertoire of serotypes.
The expansion of STs 320 and 695 in 19A appear to be at the expense of ST 199 ( Figure  2a) . The reasons for the success of these STs cannot be definitively ascertained from the data we present here, though the publication of a complete genome sequence for ST 320 has highlighted a number of features that could contribute to fitness [20] . We can be reasonably sure that this clone has enjoyed a number of selective advantages dating back to the prevaccine era, when it was an important 19F lineage. It was known prior to vaccination that ST 320 and its relatives were associated with resistance to multiple classes of antibiotics. After acquiring a 19A serotype, allowing vaccine evasion [14] , this resistance profile has been maintained. We also note the continued presence of ST 695, another example of serotype switching from a vaccine serotype. In fact, ST 695 may be more common with a 19A capsule than it was in the pre-vaccine era, when it was associated with serotype 4 (typically a rather rare serotype in carriage, though important in IPD [21] ). Both ST 320 and ST 695 are associated with a type 1 pilus, which has been documented as increasing in the pneumococcal population in Massachusetts [22] , and may contribute to fitness. Another example of serotype switching from a previously vaccine type strain is the emergence of ST 138 with a 6C capsule, which was previously a 6B strain, and has been increasing since it was recorded as a single isolate in the 2007 sample (see figure 2b ). The increase is not significant in this case (Fisher's exact p = 0.06 comparing ST 138 with all other 6C STs), but the persistence of this clone suggests some variants arising from serotype switching are likely to continue to contribute to the population. It should be noted that clones such as ST 138 6C will not be covered by PCV-13, and are expected to derive an advantage from the implementation of this vaccine. Whether serotype switching will enable ST 320 to evade vaccination a second time remains to be seen.
Highlights
• Long-term ongoing study of PCV-7 impact on pneumococcal population structure using MLST.
• Multiply resistant 19A clone ST 320 replacing previously dominant ST 199.
• Emergence of ST 138 (previously 6B capsule) with a 6C capsule
• Evidence population has reached a new equilibrium following serotype replacement
• Essential baseline data for studying PCV-13 impact
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